Viewing Study NCT00923156

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:34 PM
Ignite Modification Date: 2026-05-29 @ 3:45 PM
Study NCT ID: NCT00923156
Status: COMPLETED
Last Update Posted: 2012-07-26
First Post: 2009-06-17
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Heart failure View
None Systolic View
None Aliskiren View
None Ramipril View
None Angiotensin II View
None Ang II View
None Plasma Renin Activity View
None PRA View
None Plasma Renin Concentration View
None PR, View
None brain natriuretic peptide View
None BNP View
None urinary aldosterone View
None Escape View
None Pharmacokinetic View
None PK View